Patients are more likely to take action for their health after seeing ads that trigger fear and hope, according to new research in the 2018 Wunderman Health Inertia Study. While healthcare marketers typically jump at the chance to test out new research findings with their own audience, those who communicate clinical trial opportunities to patients may pause.
Continue reading